Quartette FDA Approval History
FDA Approved: Yes (First approved March 28, 2013)
Brand name: Quartette
Generic name: levonorgestrel/ethinyl estradiol and ethinyl estradiol
Dosage form: Tablets
Company: Teva Branded Pharmaceutical Products R&D, Inc.
Treatment for: Birth Control
Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) is a 91-day extended regimen oral contraceptive indicated for the prevention of pregnancy.
Development timeline for Quartette
| Date | Article |
|---|---|
| Mar 29, 2013 | Approval FDA Approves Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
